May 24, 2026 - 21:30

IXSAR Capital, a venture capital firm based in San Francisco, has officially launched a new platform focused specifically on Space Technology, Autonomy, and Robotics. The firm announced that the platform is designed to support technical founders who are building intelligent systems, physical AI, and advanced infrastructure.
The move comes as interest in deep tech and hardware-heavy startups continues to grow among investors. IXSAR Capital aims to fill a gap by providing not just funding but also operational support for companies working on complex engineering challenges. The firm's focus areas include autonomous systems, robotic platforms, and space-related technologies such as satellite infrastructure and in-orbit services.
According to the firm, the new platform will help founders navigate the long development cycles and capital-intensive nature of these industries. IXSAR Capital plans to work closely with portfolio companies on technical validation, supply chain strategy, and go-to-market execution.
The firm's leadership emphasized that the goal is to back founders who are building the next generation of physical and autonomous systems. With this launch, IXSAR Capital positions itself as a specialized partner for startups operating at the intersection of hardware, software, and space.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...